General Psychiatry

Learning Objectives

Learning Objectives, Light Therapy, TCPR, September 2026

September 1, 2026

After reading these articles, you should be able to…

Clinical Update

FDA Approves Bysanti: Patent Extension Gone Wild

September 1, 2026

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

The FDA just approved a new antipsychotic for schizophrenia and bipolar mania. Here's what you need to know before you prescribe it.

Expert Q&A

Light Therapy: Beyond Seasonal Depression

September 1, 2026

Norman Rosenthal, MD

Norman Rosenthal, MD. Clinical Professor of Psychiatry, Georgetown University Medical School, Washington, DC.

Dr. Rosenthal has no financial relationships with companies related to this material.

Light therapy works faster than antidepressants, helps more patients than you think, and costs nothing to prescribe. Here's how to use it.

Clinical Update

GLP1-RAs: A Psychiatric Update

September 1, 2026

David Liebers, MD

David Liebers, MD. Research Psychiatrist, Nathan Kline Institute for Psychiatric Research; Research Assistant Professor of Psychiatry, NYU Grossman School of Medicine.

Dr. Liebers reports he is principal investigator for Autobahn Therapeutics. Relevant financial relationships listed for the author have been mitigated. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.

GLP-1 receptor agonists are everywhere. The latest RCTs finally clarify what they can — and can't — do for your psychiatric patients.

Research Update

Pramipexole Shows Consistent Antidepressant Benefits Across Two RCTs, But Side Effects Limit Use

September 1, 2026

Jesse Koskey, MD.

Edited by Jesse Koskey, MD. Dr. Koskey has no financial relationships with companies related to this material.

Two new RCTs just gave an old Parkinson's drug a second look. The results for treatment-resistant depression may surprise you.

CME Post-Test, Light Therapy, TCPR, August 2026

September 1, 2026

By successfully completing the test, you will be awarded a certificate for 1 CME credit.

Research Update

Selegiline Patch May Offer Safer Option for Treatment-resistant Depression

September 1, 2026

Alla Alexander, MD

Alla Alexander, MD. Dr. Alexander has no financial relationships with companies related to this material.

Adult ADHD 4: Other Causes

August 17, 2026

Chris Aiken, MD and Kellie Newsome, PMHNP

How to separate adult ADHD from other causes of cognitive problems like bipolar disorder, sleep apnea, medication effects, brain injury, temperament, and malingering.

Adult ADHD 3: The Missing Page in DSM

August 10, 2026

Chris Aiken, MD and Kellie Newsome, PMHNP

The modern DSM began as a short list of 12 well-validated diagnoses. But the list expanded as the authors changed the goals from validity to reliability. Lost in this history is a missing page that helps separate adult ADHD from its mimics.